• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗Ku阳性患者的临床特征、肌肉病理学及自噬的作用。

The clinical features, muscle pathology, and role of autophagy in anti-Ku-positive patients.

作者信息

Qiao Lingya, Lin Ying, Liu Mengyang, Liu Jiaqi, Li Ke, Chen Juan, Shi Qiang

机构信息

Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

Department of Neurology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

出版信息

Front Immunol. 2025 Jun 17;16:1608735. doi: 10.3389/fimmu.2025.1608735. eCollection 2025.

DOI:10.3389/fimmu.2025.1608735
PMID:40599787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12209196/
Abstract

AIMS

This study aimed to examine the clinical and muscle histological characteristics of anti-Ku-positive patients. A preliminary investigation into the involvement of autophagy was conducted as well.

METHODS

Clinical characteristics, laboratory findings, and muscle histological features were collected from patients with isolated anti-Ku antibodies at the Department of Neurology, First Medical Center of the PLA General Hospital, between February 2011 to June 2024. Autophagy-related protein levels were semi-quantitatively assessed on muscle tissue samples using western blot (WB), with sporadic inclusion body myositis (sIBM) and immune-mediated necrotizing myopathy (IMNM) patients as comparison groups.

RESULTS

A total of 6 patients were recruited in the study (50% female, mean age at onset 47.6 ± 15.56 years, mean disease duration 7 ± 5.58 months). Extramuscular involvement was observed in most cases, including subcutaneous edema (33.3%), skin rash (33.3%), hyperpigmentation (33.3%), hair loss (33.3%), arthralgia (50%), and interstitial lung disease (ILD) (33.3%), etc. Coexisting connective tissue diseases included systemic sclerosis (SSc) (83.3%), systemic lupus erythematosus (SLE) (16.7%), and arthritis (16.7%). The distribution of muscle weakness was generally symmetrical and proximal (83.3%). Distal (50%) and axial (50%) muscle weakness could also be found. 2 patients exhibited peripheral nerve damage and myogenic damage in EMG, while 4 showed myogenic damage. Creatine kinase (CK) was mildly or moderately elevated. Muscle biopsy demonstrated two patterns: a neurogenic atrophy pattern and a myositis pattern characterized by a varying degree of necrotizing fibers (100%) with rimmed vacuoles (50%) or non-rimmed vacuoles (50%). Immunohistochemical (IHC) analysis revealed sarcolemma deposition of major histocompatibility complex class I (MHC-I) (83.3%) and MHC-II (83.3%), as well as predominant CD68-positive inflammatory infiltrates (66.7%). IHC for p62 revealed a sarcoplasmic punctate pattern (50%), along with a focal coarse staining pattern (50%) and occasional fine granular staining (33.3%). Electron microscopy (EM) demonstrated filamentous and lipid accumulation within vacuoles. WB analysis showed that p62 levels significantly differed between the anti-Ku and IMNM groups. Additionally, Parkin levels were highest in sIBM, while lysosome-associated membrane protein 2 (LAMP2) and microtubule-associated protein 1A/1B-light chain 3 (LC3) expression was highest in the anti-Ku-positive group in tendency.

CONCLUSION

The muscular features were heterogeneous in anti-Ku-positive patients. A predominant myositis pattern was characterized by necrotizing fibers and vacuolar changes in muscle histology, which differ from sIBM and IMNM. Autophagy appeared to be a key mechanism implicated in the pathogenesis.

摘要

目的

本研究旨在探讨抗Ku抗体阳性患者的临床及肌肉组织学特征,并初步研究自噬在其中的作用。

方法

收集2011年2月至2024年6月期间解放军总医院第一医学中心神经内科孤立性抗Ku抗体患者的临床特征、实验室检查结果及肌肉组织学特征。采用蛋白质免疫印迹法(WB)对肌肉组织样本中自噬相关蛋白水平进行半定量评估,以散发性包涵体肌炎(sIBM)和免疫介导坏死性肌病(IMNM)患者作为对照组。

结果

本研究共纳入6例患者(50%为女性,平均发病年龄47.6±15.56岁,平均病程7±5.58个月)。多数患者存在肌外表现,包括皮下水肿(33.3%)、皮疹(33.3%)、色素沉着(33.3%)、脱发(33.3%)、关节痛(50%)和间质性肺疾病(ILD)(33.3%)等。并存的结缔组织病包括系统性硬化症(SSc)(83.3%)、系统性红斑狼疮(SLE)(16.7%)和关节炎(16.7%)。肌无力分布多为对称性近端受累(83.3%),也可见远端(50%)和躯干部(50%)肌无力。2例患者肌电图显示周围神经损害和肌源性损害,4例显示肌源性损害。肌酸激酶(CK)轻度或中度升高。肌肉活检显示两种模式:神经源性萎缩模式和肌炎模式,其特征为不同程度的坏死纤维(100%),伴有镶边空泡(50%)或非镶边空泡(50%)。免疫组织化学(IHC)分析显示主要组织相容性复合体I类(MHC-I)(83.3%)和MHC-II(83.3%)在肌膜沉积,以及主要为CD68阳性的炎性浸润(66.7%)。p62免疫组化显示肌浆点状模式(50%),伴有局灶性粗染色模式(50%)和偶尔的细颗粒状染色(33.3%)。电子显微镜(EM)显示空泡内有丝状和脂质积聚。WB分析显示抗Ku组和IMNM组之间p62水平有显著差异。此外,Parkin水平在sIBM中最高,而溶酶体相关膜蛋白2(LAMP2)和微管相关蛋白1A/1B轻链3(LC3)表达在抗Ku抗体阳性组中呈升高趋势。

结论

抗Ku抗体阳性患者的肌肉特征具有异质性。主要的肌炎模式在肌肉组织学上表现为坏死纤维和空泡改变,这与sIBM和IMNM不同。自噬似乎是发病机制中的关键机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce8/12209196/98b25c06f346/fimmu-16-1608735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce8/12209196/13004e566676/fimmu-16-1608735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce8/12209196/98b25c06f346/fimmu-16-1608735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce8/12209196/13004e566676/fimmu-16-1608735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce8/12209196/98b25c06f346/fimmu-16-1608735-g002.jpg

相似文献

1
The clinical features, muscle pathology, and role of autophagy in anti-Ku-positive patients.抗Ku阳性患者的临床特征、肌肉病理学及自噬的作用。
Front Immunol. 2025 Jun 17;16:1608735. doi: 10.3389/fimmu.2025.1608735. eCollection 2025.
2
Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy.抗-Ku 阳性肌炎:获得性炎症性蛋白聚集体肌病。
Acta Neuropathol. 2024 Jul 16;148(1):6. doi: 10.1007/s00401-024-02765-3.
3
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.成人起病的临床无肌病性皮肌炎(无肌性皮肌炎)的系统评价:特发性炎性肌病谱系中的缺失环节
J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23.
4
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Characterizing local antibody responses in the muscle of inclusion body myositis patients.表征包涵体肌炎患者肌肉中的局部抗体反应。
J Autoimmun. 2025 Jun;154:103437. doi: 10.1016/j.jaut.2025.103437. Epub 2025 May 26.
10
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.针对儿童癌症治疗期间及治疗后的儿童和青少年的体育锻炼训练干预措施。
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.

本文引用的文献

1
Autophagy in myositis, a dysregulated pathway, and a target for therapy.自噬在肌炎中是一条失调的通路,也是一个治疗靶点。
Autoimmun Rev. 2025 Jun 24;24(7):103817. doi: 10.1016/j.autrev.2025.103817. Epub 2025 Apr 20.
2
Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy.抗-Ku 阳性肌炎:获得性炎症性蛋白聚集体肌病。
Acta Neuropathol. 2024 Jul 16;148(1):6. doi: 10.1007/s00401-024-02765-3.
3
Pathological autoantibody internalisation in myositis.肌炎中的病理性自身抗体内化。
Ann Rheum Dis. 2024 Oct 21;83(11):1549-1560. doi: 10.1136/ard-2024-225773.
4
Pathologic Features of Anti-Ku Myositis.抗-Ku 肌炎的病理特征。
Neurology. 2024 Apr 23;102(8):e209268. doi: 10.1212/WNL.0000000000209268. Epub 2024 Mar 28.
5
Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis.硬皮病性肌炎:系统性硬化症和自身免疫性肌炎谱中的一种独特新型实体。对护理和发病机制的影响。
Front Immunol. 2023 Jan 26;13:974078. doi: 10.3389/fimmu.2022.974078. eCollection 2022.
6
Systemic sclerosis associated myopathy.系统性硬化症相关肌病
Autoimmun Rev. 2023 Feb;22(2):103261. doi: 10.1016/j.autrev.2022.103261. Epub 2022 Dec 20.
7
Clinico-pathological phenotypes of systemic sclerosis-associated myopathy: analysis of a large multicentre cohort.系统性硬皮病相关肌病的临床病理表型:一项大型多中心队列研究分析。
Rheumatology (Oxford). 2023 Feb 6;62(SI):SI82-SI90. doi: 10.1093/rheumatology/keac361.
8
Autoantibody profiles delineate distinct subsets of scleromyositis.自身抗体谱可明确硬皮肌炎的不同亚群。
Rheumatology (Oxford). 2022 Mar 2;61(3):1148-1157. doi: 10.1093/rheumatology/keab492.
9
The phenotype of myositis patients with anti-Ku autoantibodies.抗 Ku 自身抗体阳性肌炎患者的表型。
Semin Arthritis Rheum. 2021 Aug;51(4):728-734. doi: 10.1016/j.semarthrit.2021.04.012. Epub 2021 Apr 28.
10
Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of 'scleromyositis'.具有轻度系统性硬化临床特征的肌炎患者出现毛细血管基底膜重复,支持了“硬化性肌炎”这一概念。
Acta Neuropathol. 2021 Aug;142(2):395-397. doi: 10.1007/s00401-021-02335-x. Epub 2021 Jun 11.